AKT1 and lymphoma: Either HHT, or HHT in combination with curcumin, was able to inhibit the growth and angiogenesis of lymphoma cells by targeting the Vascular Endothelial Growth Factor/Protein Kinase B (VEGF/AKT) signaling pathway (29).